bbi608
Showing 1 - 12 of 12
Metastatic Colorectal Cancer Trial in Kashiwa, Chiba, Nagoya, Aichi (BBI608, 5-FU, Irinotecan)
Completed
- Metastatic Colorectal Cancer
- BBI608
- +4 more
-
Kashiwa, Chiba, Japan
- +1 more
Apr 9, 2022
Cancer, Advanced Malignancies Trial in Greenville, Ottawa, Montreal (BBI608)
Completed
- Cancer, Advanced Malignancies
- BBI608
-
Greenville, South Carolina
- +2 more
Apr 4, 2022
Hematologic Malignancy Trial in United States (BBI608, Dexamethasone, Bortezomib)
Completed
- Hematologic Malignancy
- BBI608
- +4 more
-
Denver, Colorado
- +7 more
Apr 4, 2022
Cancer Trial in United States (BBI608, Ipilimumab, Nivolumab)
Completed
- Cancer
- BBI608
- +3 more
-
Denver, Colorado
- +7 more
Apr 4, 2022
Metastatic Pancreatic Adenocarcinoma Trial in United States (BBI608, Nab-paclitaxel, Gemcitabine)
Completed
- Metastatic Pancreatic Adenocarcinoma
- BBI608
- +7 more
-
Phoenix, Arizona
- +11 more
Apr 4, 2022
Colorectal Cancer Metastatic Trial in Australia (Nivolumab 10 MG/ML, BNC 105, BBI608)
Completed
- Colorectal Cancer Metastatic
- Nivolumab 10 MG/ML
- +2 more
-
Albury, New South Wales, Australia
- +13 more
Aug 26, 2021
Gastric Cancer, Gastroesophageal Junction Cancer Trial in Worldwide (BBI608, Paclitaxel, Placebo)
Completed
- Gastric Cancer
- Gastroesophageal Junction Cancer
- BBI608
- +2 more
-
Scottsdale, Arizona
- +262 more
Apr 4, 2022
Colorectal Carcinoma Trial in Australia, Canada, Japan (BBI608, Placebo, Best Supportive Care)
Completed
- Colorectal Carcinoma
- BBI608
- +2 more
-
Bankstown, New South Wales, Australia
- +62 more
Apr 2, 2020